Artha Sootra - Company Dashboard

Governance Classic Home

Concord Biotech LtdPharmaceuticalsINE338H01029Consolidated₹655.20+40.28 (+6.55%)

Valuation

Market Cap₹6.86K Cr

TTM PE49.06x

Forward PE47.66x

PEG20.61

Book Value₹198.42

P/B3.30x

TTM EPS₹13.36

Fwd EPS₹13.75

TTM Revenue₹1.17K Cr

TTM PAT₹279.38 Cr

TTM EBITDA₹404.27 Cr

TTM EBIT₹329.50 Cr

Last Qtr PAT₹69.57 Cr

Last Qtr EBITDA₹104.38 Cr

Last Qtr EBIT₹86.00 Cr

Profitability

ROE13.46%

ROCE18.03%

TTM NPM23.87%

TTM EBITDA %34.54%

Curr OPM21.79%

Last OPM21.35%

Curr NPM—

Last NPM—

Curr EPS₹3.33

Last EPS₹2.76

Balance sheet

Equity₹10.46 Cr

Reserve₹2.07K Cr

Total Debt₹1.75 Cr

D/E0.00x

Interest %0.04%

Curr Interest₹0.03 Cr

Price / range

Close₹655.50

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D-46.62%

1W+3.26%

1M-4.70%

3M-7.80%

6M+9.65%

1Y-10.02%

2Y-27.68%

3Y—

5Y—

Diwali-50.97%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1773.40	₹4.25L Cr	38.81	12.31%
DIVISLAB	10037.50	₹2.66L Cr	91.08	17.45%
TORNTPHARM	4738.50	₹1.60L Cr	77.77	11.42%
LAURUSLABS	2323.80	₹1.25L Cr	93.63	21.98%
ZYDUSLIFE	1188.10	₹1.20L Cr	28.53	15.79%
DRREDDY	1374.00	₹1.15L Cr	40.89	7.11%
CIPLA	1402.00	₹1.13L Cr	39.09	8.06%
MANKIND	2537.90	₹1.05L Cr	46.71	12.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	312.31+26.4%	260.52	325.89	278.13	247.06	1,055.07
Other Income	10.45	13.10	15.54	10.08	13.43	52.73
Total Income	322.77+23.9%	273.61	341.43	288.22	260.49	1,107.80
Interest	0.01	0.02	0.06	0.06	0.06	0.23
Expenditure	-220.85-26.2%	-191.40	-223.06	-194.64	-174.97	-753.09
PBDT	0	0	0	0	0	0
EBITDA	109.81+21.3%	87.19	122.38	102.22	90.54	376.54
Depreciation	-18.34	-18.05	-19.49	-18.67	-18.39	-74.33
EBIT	91.47+26.8%	69.14	102.89	83.55	72.15	302.21
PBT	101.92+19.2%	82.21	118.38	90.30	85.52	351.43
Tax	-26.21	-21.02	-28.36	-22.51	-22.62	-88.17
Equity	10.46	10.46	10.46	10.46	0	10.46
OPM	31.58	30.05	34.67	31.33	34.61	31.72
Net Profit	75.71+20.4%	61.19	90.02	67.78	62.90	263.27
NPM	23.46	22.36	26.37	23.52	25.46	23.76
EPS	7.24+20.5%	5.85	8.60	6.48	6.01	25.17

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24
Revenue	1,055.07-12.1%	1,200.09+18.0%	1,016.94
Other Income	52.73	44.45	33.78
Total Income	1,107.80-11.0%	1,244.53+18.4%	1,050.72
Expenditure	-753.09-0.6%	-748.66-16.7%	-641.53
Interest	-0.23	-0.53	-2.55
PBDT	0	0	0
EBITDA	376.54-25.6%	506.33+17.3%	431.55
Depreciation	-74.33	-54.37	-53.59
EBIT	302.21-33.1%	451.96+19.6%	377.96
PBT	351.43-29.1%	495.88+21.2%	409.19
Tax	-88.17	-122.91	-104.46
Equity	10.46	10.46	0
OPM (%)	31.72	39.84	39.00
Net Profit	263.27-29.4%	372.96+22.4%	304.73
NPM (%)	23.76	29.97	29.00
EPS (Rs)	25.17-29.4%	35.65+22.4%	29.13
CEPS	25.17	35.65	29.13

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	309.07+25.1%	257.49	326.08	277.77	247.06	1,054.89
Other Income	10.17	12.83	15.35	9.98	13.35	52.36
Total Income	319.24+22.6%	270.31	341.43	287.74	260.41	1,107.25
Interest	0.03	0.04	0.08	0.08	0.06	0.28
Expenditure	-223.10-26.0%	-193.25	-227.18	-197.61	-177.02	-762.23
PBDT	0	0	0	0	0	0
EBITDA	104.38+18.0%	82.38	118.52	98.99	88.49	367.40
Depreciation	-18.38	-18.10	-19.54	-18.75	-18.39	-74.46
EBIT	86+22.7%	64.28	98.98	80.24	70.10	292.94
PBT	96.14+15.3%	77.07	114.25	86.85	83.39	341.74
Tax	-25.91	-20.65	-25.61	-22.51	-22.62	-85.42
Equity	10.46	10.46	10.46	0	0	10.46
OPM	30.12	28.51	33.46	30.18	32.02	30.86
Net Profit	69.57+10.3%	57.70	88.47	63.64	63.06	259.23
NPM	21.79	21.35	25.91	22.12	24.22	23.41
EPS	6.65+10.3%	5.52	8.46	6.08	6.03	24.78

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24
Revenue	1,054.89-12.1%	1,200.09+18.0%	1,016.94
Other Income	52.36	44.45	33.78
Total Income	1,107.25-11.0%	1,244.53+18.4%	1,050.72
Expenditure	-762.23-1.8%	-748.66-16.7%	-641.53
Interest	-0.28	-0.53	-2.55
PBDT	0	0	0
EBITDA	367.40-27.4%	506.33+17.3%	431.55
Depreciation	-74.46	-54.37	-53.59
EBIT	292.94-35.2%	451.96+19.6%	377.96
PBT	341.74-31.1%	495.88+21.2%	409.19
Tax	-85.42	-122.91	-104.46
Equity	10.46	10.46	0
OPM (%)	30.86	39.84	38.94
Net Profit	259.23-30.2%	371.64+20.6%	308.10
NPM (%)	23.41	29.86	29.32
EPS (Rs)	24.78-30.2%	35.52+20.6%	29.45
CEPS	24.78	35.52	29.45

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	7.55	24 Jul 2026
2025	Final Dividend	10.7	03 Sep 2025
2024	Final Dividend	8.75	21 Jun 2024

Bonus

Year	Ratio	Ex-Date
2026	1:1	04 Nov 2026

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split